The discovery of recurrent ETS-family translocations in prostate cancer[3,4], a RAF kinase gene fusion in ETS-negative prostate cancer[5,6], and an ALK kinase fusion in lung cancer[7] further advocates the significance of gene fusion events in the development of epithelial cancers[8,9]. The gene discussed is ALK; the disease is prostate cancer.